Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Martín-Merino, Elisa
1241  Ergebnisse:
Personensuche X
?
1

Risk of agranulocytosis with metamizole in comparison with ..:

Maciá-Martínez, Miguel-Ángel ; Castillo-Cano, Belén ; García-Poza, Patricia.
European Journal of Clinical Pharmacology.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

Effectiveness of homologous/heterologous booster COVID-19 v..:

Riefolo, Fabio ; Castillo-Cano, Belén ; Martín-Pérez, Mar...
Vaccine.  41 (2023)  47 - p. 7007-7018 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Effectiveness of a Second Dose of an mRNA Vaccine Against S..:

Monge, Susana ; Rojas-Benedicto, Ayelén ; Olmedo, Carmen...
Clinical Infectious Diseases.  76 (2022)  3 - p. e367-e374 , 2022
Link: https://doi.org/10.1093/..
 
?
4

Development and external validation of a 1- and 5-year frac..:

Tebé, Cristian ; Pallarès, Natalia ; Reyes, Carlen...
Bone.  162 (2022)  - p. 116469 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Assessment of thyroiditis risk associated with HPV vaccinat..:

Castillo-Cano, Belén ; Martín-Pérez, Mar ; Llorente-García, Ana...
Vaccine.  40 (2022)  33 - p. 4816-4826 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Papillomavirus vaccination and Guillain-Barre Syndrome amon..:

Martín-Merino, Elisa ; Castillo-Cano, Belen ; Martín-Perez, Mar..
Vaccine.  39 (2021)  31 - p. 4306-4313 , 2021
Link: https://doi.org/10.1016/..
 
?
7

BIFAP Program: A Data Resource for Pharmacoepidemiological ..:

, In: Databases for Pharmacoepidemiological Research; Springer Series on Epidemiology and Public Health,
Dolores Montero on behalf of BIFAP Team ; Gil, Miguel ; Maciá, Miguel Angel... - p. 165-187 , 2021
Link: https://doi.org/10.1007/..
 
?
8

Effectiveness of mRNA COVID-19 vaccines in preventing SARS-..:

Mazagatos, Clara ; Monge, Susana ; Olmedo, Carmen...
Eurosurveillance.  26 (2021)  24 - p. , 2021
Link: https://doi.org/10.2807/..
 
?
9

Evaluation of the Risk of Inflammatory Bowel Disease after ..:

Martín-Merino, Elisa ; Castillo-Cano, Belén ; Martín-Pérez, Mar..
Drug Safety.  44 (2021)  4 - p. 455-466 , 2021
Link: https://doi.org/10.1007/..
 
?
10

Incidence Rates of Autoimmune Diseases in European Healthca..:

Willame, Corinne ; Dodd, Caitlin ; van der Aa, Lieke...
Drug Safety.  44 (2021)  3 - p. 383-395 , 2021
Link: https://doi.org/10.1007/..
 
?
11

ADVANCE system testing: Benefit-risk analysis of a marketed..:

Bollaerts, Kaatje ; Ledent, Edouard ; de Smedt, Tom...
Vaccine.  38 (2020)  - p. B65-B75 , 2020
Link: https://doi.org/10.1016/..
 
?
12

ADVANCE database characterisation and fit for purpose asses..:

Sturkenboom, Miriam ; Braeye, Toon ; van der Aa, Lieke...
Vaccine.  38 (2020)  - p. B8-B21 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Advance system testing: Vaccine benefit studies using multi..:

Tin Tin Htar, Myint ; de Ridder, Maria ; Braeye, Toon...
Vaccine.  38 (2020)  - p. B31-B37 , 2020
Link: https://doi.org/10.1016/..
 
?
14

ADVANCE system testing: Can coverage of pertussis vaccinati..:

Emborg, Hanne-Dorthe ; Kahlert, Johnny ; Braeye, Toon...
Vaccine.  38 (2020)  - p. B22-B30 , 2020
Link: https://doi.org/10.1016/..
 
?
15

ADVANCE system testing: Estimating the incidence of adverse..:

Dodd, Caitlin ; de Ridder, Maria ; Weibel, Daniel...
Vaccine.  38 (2020)  - p. B47-B55 , 2020
Link: https://doi.org/10.1016/..
 
1-15